However, identification of novel mediators and a better understanding of the different metabolic pathways associated with the leptin signaling could result in the development of new potential therapeutic strategies to tackle obesity and its related metabolic disorders. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.